RxDoctor Payments DataLook up a doctor →

DEXCOM STELO GLUCOSE BIOSENSOR: payments to doctors

Payments that named DEXCOM STELO GLUCOSE BIOSENSOR as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$1.7M
Providers
2,048
Transactions
3,519
Average per transaction
$471

The per-transaction average — $471 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,048 providers the average total is $809, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Dexcom, Inc.$1,656,144100.0%
← All drugs & devices